Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-20-005372
Filing Date
2020-03-16
Accepted
2020-03-16 21:05:22
Documents
1
Period of Report
2020-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 2892
  Complete submission text file 0001437749-20-005372.txt   4240
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Issuer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16402 EMILIA COURT SPRING TX 77379
Business Address
Redman Michael Thomas (Reporting) CIK: 0001703052 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38244 | Film No.: 20719034